Changshan Pharmaceutical Industry: enoxaparin Sodium injection obtains Nicaraguan Drug Registration Certificate

[Changshan Pharmaceutical Industry: enoxaparin Sodium injection obtains Nicaraguan Drug Registration Certificate] June 14, Changshan Pharmaceutical Industry announced that the company's drug enoxaparin sodium injection has obtained a drug registration certificate issued by the Ministry of Health of Nicaragua. Enoxaparin sodium injection is used to prevent venous thromboembolic diseases (prevention of venous thrombosis), especially thrombosis related to orthopedic or general surgery.